Cantillon Capital Management LLC raised its stake in Agilent Technologies Inc (NYSE:A) by 11.5% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,945,223 shares of the medical research company’s stock after buying an additional 405,598 shares during the period. Agilent Technologies makes up about 3.0% of Cantillon Capital Management LLC’s investment portfolio, making the stock its 17th largest holding. Cantillon Capital Management LLC’s holdings in Agilent Technologies were worth $294,589,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently bought and sold shares of A. Flagship Harbor Advisors LLC raised its stake in Agilent Technologies by 139.0% during the 2nd quarter. Flagship Harbor Advisors LLC now owns 349 shares of the medical research company’s stock valued at $26,000 after purchasing an additional 203 shares during the period. Destination Wealth Management raised its stake in Agilent Technologies by 100.0% during the 1st quarter. Destination Wealth Management now owns 400 shares of the medical research company’s stock valued at $32,000 after purchasing an additional 200 shares during the period. Financial Gravity Wealth Inc. acquired a new stake in Agilent Technologies during the 1st quarter valued at $52,000. Knuff & Co LLC raised its stake in Agilent Technologies by 203.3% during the 1st quarter. Knuff & Co LLC now owns 910 shares of the medical research company’s stock valued at $73,000 after purchasing an additional 610 shares during the period. Finally, NEXT Financial Group Inc raised its stake in Agilent Technologies by 22.0% during the 2nd quarter. NEXT Financial Group Inc now owns 925 shares of the medical research company’s stock valued at $69,000 after purchasing an additional 167 shares during the period.
Several equities analysts have recently commented on the stock. Wolfe Research assumed coverage on shares of Agilent Technologies in a report on Thursday, May 30th. They set a “peer perform” rating on the stock. Barclays cut shares of Agilent Technologies from an “overweight” rating to an “equal weight” rating and lowered their price target for the company from $86.00 to $78.00 in a report on Monday, July 15th. Piper Jaffray Companies assumed coverage on shares of Agilent Technologies in a report on Tuesday, June 11th. They set an “overweight” rating and a $83.00 price target on the stock. Deutsche Bank lowered their price target on shares of Agilent Technologies from $90.00 to $85.00 and set a “buy” rating on the stock in a report on Wednesday, May 15th. Finally, Zacks Investment Research cut shares of Agilent Technologies from a “hold” rating to a “sell” rating and set a $71.00 price target on the stock. in a report on Tuesday, July 16th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have given a buy rating to the company’s stock. Agilent Technologies has a consensus rating of “Buy” and a consensus price target of $83.92.
Agilent Technologies (NYSE:A) last released its earnings results on Tuesday, May 14th. The medical research company reported $0.71 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.72 by ($0.01). The firm had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.27 billion. Agilent Technologies had a return on equity of 19.71% and a net margin of 22.25%. The firm’s revenue was up 2.7% on a year-over-year basis. During the same period in the prior year, the firm earned $0.65 EPS. Analysts forecast that Agilent Technologies Inc will post 3.05 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Wednesday, July 24th. Shareholders of record on Tuesday, July 2nd were given a dividend of $0.164 per share. This represents a $0.66 dividend on an annualized basis and a yield of 0.97%. The ex-dividend date of this dividend was Monday, July 1st. Agilent Technologies’s dividend payout ratio is 23.66%.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Recommended Story: Percentage Decliners
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.